James W. Antoon

2.5k total citations
96 papers, 1.7k citations indexed

About

James W. Antoon is a scholar working on Epidemiology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, James W. Antoon has authored 96 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 21 papers in Molecular Biology and 17 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in James W. Antoon's work include Sphingolipid Metabolism and Signaling (12 papers), Influenza Virus Research Studies (8 papers) and Pharmaceutical studies and practices (8 papers). James W. Antoon is often cited by papers focused on Sphingolipid Metabolism and Signaling (12 papers), Influenza Virus Research Studies (8 papers) and Pharmaceutical studies and practices (8 papers). James W. Antoon collaborates with scholars based in United States, Australia and Chile. James W. Antoon's co-authors include Barbara S. Beckman, Matthew E. Burow, Steven Elliott, Lyndsay V. Rhodes, Shannon E. Muir, Derek J. Williams, Carlos G. Grijalva, Jennifer Driver, Richard L. Miller and Matt Hall and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

James W. Antoon

93 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James W. Antoon United States 26 678 277 254 199 188 96 1.7k
Manish Tandon United States 26 669 1.0× 336 1.2× 204 0.8× 107 0.5× 130 0.7× 96 2.0k
Robert Öllinger Germany 28 1.3k 1.9× 259 0.9× 331 1.3× 165 0.8× 110 0.6× 135 3.0k
Timothy R. McGuire United States 22 455 0.7× 245 0.9× 163 0.6× 46 0.2× 164 0.9× 66 1.5k
Dennis E. Doherty United States 30 656 1.0× 185 0.7× 237 0.9× 145 0.7× 171 0.9× 80 3.2k
S. Aubrey Stoch United States 20 526 0.8× 636 2.3× 237 0.9× 64 0.3× 50 0.3× 74 1.6k
Yijun Yang United States 24 634 0.9× 199 0.7× 291 1.1× 60 0.3× 154 0.8× 56 1.9k
Steven J. Kern United States 17 414 0.6× 289 1.0× 318 1.3× 369 1.9× 41 0.2× 32 1.6k
M G Coulthard Australia 26 448 0.7× 94 0.3× 378 1.5× 102 0.5× 48 0.3× 81 2.0k
Helmut Reichel Germany 24 503 0.7× 347 1.3× 193 0.8× 143 0.7× 69 0.4× 78 3.2k
Deborah P. Jones United States 28 520 0.8× 259 0.9× 241 0.9× 287 1.4× 39 0.2× 67 2.6k

Countries citing papers authored by James W. Antoon

Since Specialization
Citations

This map shows the geographic impact of James W. Antoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James W. Antoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James W. Antoon more than expected).

Fields of papers citing papers by James W. Antoon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James W. Antoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James W. Antoon. The network helps show where James W. Antoon may publish in the future.

Co-authorship network of co-authors of James W. Antoon

This figure shows the co-authorship network connecting the top 25 collaborators of James W. Antoon. A scholar is included among the top collaborators of James W. Antoon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James W. Antoon. James W. Antoon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Williams, Derek J., et al.. (2025). Serious Neurologic Events With Seasonal Influenza in Young Children. Academic Pediatrics. 25(4). 102801–102801. 2 indexed citations
2.
Girdwood, Sonya Tang, Matt Hall, James W. Antoon, et al.. (2024). Opportunities for Pharmacogenetic Testing to Guide Dosing of Medications in Youths With Medicaid. JAMA Network Open. 7(2). e2355707–e2355707. 1 indexed citations
3.
Antoon, James W., Hui Nian, Krow Ampofo, et al.. (2023). Validation of Childhood Pneumonia Prognostic Models for Use in Emergency Care Settings. Journal of the Pediatric Infectious Diseases Society. 12(8). 451–458. 4 indexed citations
4.
Antoon, James W., et al.. (2023). Advancing pediatric medication safety using real‐world data: Current problems and potential solutions. Journal of Hospital Medicine. 18(9). 865–869. 2 indexed citations
5.
Antoon, James W., et al.. (2023). Population-Based Incidence of Influenza-Associated Serious Neuropsychiatric Events in Children and Adolescents. JAMA Pediatrics. 177(9). 967–967. 7 indexed citations
6.
Hall, Matt, Derek J. Williams, James W. Antoon, et al.. (2022). Pharmacologic restraint use for children experiencing mental health crises in pediatric hospitals. Journal of Hospital Medicine. 18(2). 120–129. 5 indexed citations
7.
Hall, Matt, Charlotte M. Brown, David Johnson, et al.. (2021). Association of Race/Ethnicity and Social Determinants with Rehospitalization for Mental Health Conditions at Acute Care Children's Hospitals. The Journal of Pediatrics. 240. 228–234.e1. 9 indexed citations
8.
Arnold, Donald H., Wu Gong, James W. Antoon, et al.. (2021). Prospective Observational Study of Clinical Outcomes After Intravenous Magnesium for Moderate and Severe Acute Asthma Exacerbations in Children. The Journal of Allergy and Clinical Immunology In Practice. 10(5). 1238–1246. 10 indexed citations
9.
Antoon, James W., Matt Hall, Alison Herndon, et al.. (2021). Prevalence, Risk Factors, and Outcomes of Influenza-Associated Neurologic Complications in Children. The Journal of Pediatrics. 239. 32–38.e5. 31 indexed citations
10.
Harrington, Rachel, Sruthi Adimadhyam, Todd A. Lee, Glen T. Schumock, & James W. Antoon. (2018). The Relationship Between Oseltamivir and Suicide in Pediatric Patients. The Annals of Family Medicine. 16(2). 145–148. 17 indexed citations
11.
Parikh, Kavita, Matt Hall, Chén C. Kenyon, et al.. (2018). Impact of Discharge Components on Readmission Rates for Children Hospitalized with Asthma. The Journal of Pediatrics. 195. 175–181.e2. 10 indexed citations
12.
Antoon, James W., et al.. (2016). Evans Syndrome Secondary to Common Variable Immune Deficiency. Journal of Pediatric Hematology/Oncology. 38(3). 243–245. 5 indexed citations
13.
Liu, Jiawang, Kaustubh N. Bhinge, James W. Antoon, et al.. (2014). 3-Ketone-4,6-diene ceramide analogs exclusively induce apoptosis in chemo-resistant cancer cells. Bioorganic & Medicinal Chemistry. 22(4). 1412–1420. 15 indexed citations
14.
Chan, Lucas, et al.. (2013). Targeting ovarian cancer and chemoresistance through selective inhibition of sphingosine kinase-2 with ABC294640.. PubMed. 33(9). 3573–9. 34 indexed citations
15.
Antoon, James W., Elizabeth C. Martin, Lyndsay V. Rhodes, et al.. (2013). Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition. International Journal of Oncology. 42(4). 1139–1150. 29 indexed citations
16.
Bratton, Melyssa R., James W. Antoon, Daniel E. Frigo, et al.. (2012). Gαo potentiates estrogen receptor α activity via the ERK signaling pathway. Journal of Endocrinology. 214(1). 45–54. 17 indexed citations
17.
Antoon, James W., Melyssa R. Bratton, Lyndsay V. Rhodes, et al.. (2011). Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer. Journal of Molecular Endocrinology. 46(3). 205–216. 46 indexed citations
18.
Antoon, James W., Jennifer Driver, Steven Elliott, et al.. (2011). Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2. Cancer Biology & Therapy. 11(7). 678–689. 126 indexed citations
19.
Antoon, James W., et al.. (2010). Novel d-erythro N-octanoyl sphingosine analogs as chemo- and endocrine-resistant breast cancer therapeutics. Cancer Chemotherapy and Pharmacology. 65(6). 1191–1195. 22 indexed citations
20.
Antoon, James W.. (2007). IS IT UNETHICAL TO OFFER INCENTIVES FOR PATIENT REFERRALS?. The Journal of the American Dental Association. 138(3). 393–394. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manish Tandon Breakdown of academic impact, for papers by Robert Öllinger Breakdown of academic impact, for papers by Timothy R. McGuire Breakdown of academic impact, for papers by Dennis E. Doherty Breakdown of academic impact, for papers by S. Aubrey Stoch Breakdown of academic impact, for papers by Yijun Yang Breakdown of academic impact, for papers by Steven J. Kern Breakdown of academic impact, for papers by M G Coulthard Breakdown of academic impact, for papers by Helmut Reichel Breakdown of academic impact, for papers by Deborah P. Jones
Rankless by CCL
2026